Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Coats

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of Medicinal Chemistry|June 9, 2017
2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in CultureShaoman Zhou, Sawsan Mahmoud, Peng Liu, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094Maryam Ehteshami, Sijia Tao, Tugba Ozturk, et al.
Antiviral Research|November 27, 2013
Chutes and ladders in hepatitis C nucleoside drug developmentSteven J Coats, Ethel C Garnier-Amblard, Franck Amblard, et al.
Journal of Medicinal Chemistry|January 18, 2019
Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C VirusSeema Mengshetti, Longhu Zhou, Ozkan Sari, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of Medicinal Chemistry|June 9, 2017
2'-Chloro,2'-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in CultureShaoman Zhou, Sawsan Mahmoud, Peng Liu, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
Biochemical Characterization of the Active Anti-Hepatitis C Virus Metabolites of 2,6-Diaminopurine Ribonucleoside Prodrug Compared to Sofosbuvir and BMS-986094Maryam Ehteshami, Sijia Tao, Tugba Ozturk, et al.
Antiviral Research|November 27, 2013
Chutes and ladders in hepatitis C nucleoside drug developmentSteven J Coats, Ethel C Garnier-Amblard, Franck Amblard, et al.
Journal of Medicinal Chemistry|January 18, 2019
Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C VirusSeema Mengshetti, Longhu Zhou, Ozkan Sari, et al.
Pageof 6